Computational Biology

Lux Capital

Check: No verified personal or standard Lux check-size range is published. Tess invests at both early and growth stages and participates in Lux company creation; founders should confirm round fit directly rather than infer an allocation from fund size or disclosed company rounds.

Tess is a technically trained generalist investing where AI, biology, aerospace, and the physical world intersect. She seeks engineers and scientists turning frontier research into companies, with particular interest in computational methods that make biology more engineerable, the data and model bottlenecks behind scientific discovery, and high-consequence systems such as biodefense.

Lux Capital

Check: Firm-level: Lux says it can invest from an initial $100K through high-conviction follow-ons as large as $100M across the company-building arc. This is not Shaq's personal standard check range.

Shaq partners with technical founders building instruments that make invisible physical or biological signals legible and platforms whose downstream value exceeds the value captured by the initial product alone. His experience in aerospace sensing, genomic measurement, liquid biopsy, enterprise technology, and healthcare supports a cross-domain lens on building-block technologies, defensibility, value capture, and the exact job AI performs inside a scientific workflow.

Lux Capital

Check: Firm-level: Lux says it can invest from an initial $100K through high-conviction follow-ons as large as $100M across the company-building arc. This is not David's personal standard check range.

David backs scientific founders in therapeutics, R&D tooling, and biopharma infrastructure, looking for research edges early enough to matter. His research and company-building background supports a translational lens: find important science before it is broadly distributed, test whether the platform creates a repeatable advantage rather than a single asset, and build the operational infrastructure required to turn experimental insight into durable medicines or tools.

Lux Capital

Check: Firm-level: Lux says it can invest from an initial $100K through high-conviction follow-ons as large as $100M across the company-building arc. This is not Lan's personal standard check range.

Lan is a Lux generalist with a defined intersection across computation and biology: computational analytics in biotech and healthcare, data and ML infrastructure, platform therapeutics, developer tooling, and AI applications. Her investment lens centers on scrappy, independently curious underdogs working at technical frontiers and developing knowledge through experimentation rather than consensus.